Drug
In10028
In10028: highest development phase Phase 1, developed by InxMed (Shanghai) Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- InxMed (Shanghai) Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| IN10028 NCT07596381 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow In10028 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.